Re-Evaluating Limitations in Atopic Dermatitis Meta-Analysis Is Important in Interpreting its Results Efstratios VakirlisAikaterini TsentemeidouStamatios Gregoriou Commentary Open access 17 November 2021 Pages: 1 - 3
Arthritis Interception in Patients with Psoriasis Treated with Guselkumab Alen ZabottiIvan GiovanniniEnzo Errichetti Commentary Open access 27 November 2021 Pages: 5 - 8
Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year Andrew BlauveltMarjolein de Bruin-WellerAna B. Rossi Commentary Open access 07 January 2022 Pages: 9 - 13
Clinical Remission of Chronic Spontaneous Urticaria (CSU): A Targeted Literature Review Maria-Magdalena BalpAnna C. HallidayAlexander M. Marsland Review Open access 22 November 2021 Pages: 15 - 27
Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management Amy C. M. MusiekKerri E. RiegerYoun H. Kim Review Open access 23 November 2021 Pages: 29 - 40
Microneedling and Its Use in Hair Loss Disorders: A Systematic Review Robert S. English Jr.Sophia RuizPedro DoAmaral Review Open access 01 December 2021 Pages: 41 - 60
Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey Mark LebwohlRichard G. LangleyPaolo Gisondi Original Research Open access 25 October 2021 Pages: 61 - 78
Correction to: Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey Mark LebwohlRichard G. LangleyPaolo Gisondi Correction Open access 06 January 2022 Pages: 79 - 79
Real-World Experience of Patient-Relevant Benefits and Treatment Satisfaction with Apremilast in Patients with Psoriasis: An Analysis of the APPRECIATE Study Toni Maria KleinChristine BlomeMatthias Augustin Original Research Open access 23 November 2021 Pages: 81 - 95
Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas’ Psoriasis Registry Jessica A. WalshKristina Callis DuffinJoseph F. Merola Original Research Open access 25 November 2021 Pages: 97 - 119
Certolizumab Pegol in Japanese Patients with Moderate to Severe Plaque Psoriasis: Effect of Demographics and Baseline Disease Characteristics on Efficacy Shinichi ImafukuYayoi TadaHidemi Nakagawa Original Research Open access 26 November 2021 Pages: 121 - 135
Clinical Tailoring of Baricitinib 2 mg in Atopic Dermatitis: Baseline Body Surface Area and Rapid Onset of Action Identifies Response at Week 16 Jonathan I. SilverbergMark BoguniewiczEric L. Simpson Original Research Open access 30 November 2021 Pages: 137 - 148
Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata Kathleen W. WyrwichRandall WinnetteLauren Nelson Original Research Open access 30 November 2021 Pages: 149 - 166
Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis April W. ArmstrongAhmed M. SolimanLuis Puig Original Research Open access 04 December 2021 Pages: 167 - 184
Matching-Adjusted Indirect Comparison of Crisaborole Ointment 2% vs. Topical Calcineurin Inhibitors in the Treatment of Patients with Mild-to-Moderate Atopic Dermatitis Howard ThomVincent ChengJacob P. Thyssen Original Research Open access 08 December 2021 Pages: 185 - 194
Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment April ArmstrongAndrew BlauveltPaul Tomondy Original Research Open access 13 December 2021 Pages: 195 - 202
Quality-of-Life Outcomes, Effectiveness and Tolerability of Apremilast in Patients with Plaque Psoriasis and Routine German Dermatology Care: Results from LAPIS-PSO Kristian ReichBernhard KorgeKatrin Lorenz-Baath Original Research Open access 15 December 2021 Pages: 203 - 221
Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 Weeks Andrew BlauveltMarjolein de Bruin-WellerBrad Shumel Brief Report Open access 22 November 2021 Pages: 223 - 231
Nail Involvement as a Predictor of Differential Treatment Effects of Secukinumab Versus Ustekinumab in Patients with Moderate to Severe Psoriasis Curdin ConradChristine-Elke OrtmannKristian Reich Brief Report Open access 06 December 2021 Pages: 233 - 241
Clinical Utility of Silk-Elastin Sponge in Patients with Chronic and Acute Skin Ulcers: Study Protocol of a Multicenter Clinical Trial Kazuo NodaYasuhiro KatayamaNaoki Morimoto Study Protocol Open access 30 November 2021 Pages: 243 - 252
Practical and Relevant Guidelines for the Management of Psoriasis: An Inference-Based Methodology Kim A. PappMelinda J. GooderhamRonald B. Vender Study Protocol Open access 22 December 2021 Pages: 253 - 265